FDA DEVICE FACTS
BIOGEL PS SURGICAL GLOVE SERIES, BIOGEL SKINSENSE SURGICAL GLOVE SERIES
Molnlycke Health Care Us, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Biogel® Skinsense® Surgical Gloves are intended to be worn on the hands, usually in surgical settings, to provide barrier against potentially infectious material, and other contaminants. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: Biogel® Skinsense® Drug and Concentration Breakthrough Detection Time in Minutes (0.01 µg/cm2/ minutes) Bleomycin 15 mg/ml >240 Busulfan 6 mg/ml >240 Carmustine 3.3 mg/ml 60.2 Cisplatin 1.0 mg/ml >240 Cyclophosphamide (Cytoxan) 20 mg/ml >240 Cytarabine 100 mg/ml >240 Dacarbazine (DTIC) 10 mg/ml >240 Doxorubicin Hydrochloride 2 mg/ml >240 Ellence 2 mg/ml >240 Etoposide (Toposar) 20 mg/ml >240 Fludarabine 25 mg/ml >240 Fluorouracil 50 mg/ml >240 Idarubicin 1 mg/ml >240 Ifosfamide 50 mg/ml >240 Mechlorethamine HCl 1 mg/ml >240 Melphalan 5 mg/ml >240 Methotrexate 25 mg/ml >240 Mitomycin C 0.5 mg/ml >240 Mitoxantrone 2 mg/ml >240 Paclitaxel (Taxol) 6 mg/ml >240 Paraplatin 10 mg/ml >240 Rituximab 10 mg/ml >240 Thiotepa 10 mg/ml 75.8 Trisenox 0.1 mg/ml >240 Vincristine Sulfate 1 mg/ml >240 Please note that Carmustine (3.3 mg/ml) and Thiotepa (10 mg/ml) have much lower permeation times compare to other chemotherapy drugs: Carmustine (BCNU) (3.3 mg/ml) has a minimum breakthrough time of 60.2 minutes. Thiotepa (10 mg/ml) has a minimum breakthrough time of 75.8 minutes. Biogel® PI UltraTouch™ G Surgical Gloves are intended to be worn on the hands, usually in surgical settings, to provide barrier against potentially infectious material, and other contaminants. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: Biogel® PI UltraTouch™ G Drug and Concentration Breakthrough Detection Time in Minutes (0.01 µg/cm2/ minutes) Bleomycin 15 mg/ml >240 Busulfan 6 mg/ml >240 Carmustine 3.3 mg/ml 12.1 Cisplatin 1.0 mg/ml >240 Cyclophosphamide (Cytoxan) 20 mg/ml >240 Cytarabine 100 mg/ml >240 Dacarbazine (DTIC) 10 mg/ml >240 Doxorubicin Hydrochloride 2 mg/ml >240 Ellence 2 mg/ml >240 Etoposide (Toposar) 20 mg/ml >240 Fludarabine 25 mg/ml >240 Fluorouracil 50 mg/ml >240 Idarubicin 1 mg/ml >240 Ifosfamide 50 mg/ml >240 Mechlorethamine HCl 1 mg/ml >240 Melphalan 5 mg/ml >240 Methotrexate 25 mg/ml >240 Mitomycin C 0.5 mg/ml >240 Mitoxantrone 2 mg/ml >240 Paclitaxel (Taxol) 6 mg/ml >240 Paraplatin 10 mg/ml >240 Rituximab 10 mg/ml >240 Thiotepa 10 mg/ml 15.5 Trisenox 0.1 mg/ml >240 Vincristine Sulfate 1 mg/ml >240 Please note that Carmustine (3.3 mg/ml) and Thiotepa (10 mg/ml) have much lower permeation times compare to other chemotherapy drugs: Carmustine (BCNU) (3.3 mg/ml) has a minimum breakthrough time of 12.1 minutes. Thiotepa (10 mg/ml) has a minimum breakthrough time of 15.5 minutes
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。